The rich are pouring millions into life extension research – but does it have any ethical value?
Melbourne: Sam Altman, the chief executive of OpenAI, recently invested $180 million into Retro Biosciences – a company seeking to ...
Read moreMelbourne: Sam Altman, the chief executive of OpenAI, recently invested $180 million into Retro Biosciences – a company seeking to ...
Read moreNew York: People infected with SARS-CoV-2, the virus that causes Covid-19, may experience genome structure changes that not only may ...
Read moreLondon: Being vaccinated against Covid halves people's risk of developing long Covid, according to new research conducted on more than ...
Read moreNew York: People get happy as they earn more, according to a new study which overturns the dominant thinking that ...
Read moreNew Delhi: Researchers have used the body's own immune cells to develop a nano-vaccine against COVID-19, according to a new ...
Read moreLondon: More than 40 per cent patients, who suffered Covid-19 disease, are at an increased risk of developing autoimmune disease ...
Read moreBeijing: People living with chronic pain conditions in the knee, neck and back due to ailments such as arthritis or ...
Read moreCovid-19 patients have an elevated risk of death for at least 18 months after they got infected, researchers warned Thursday.
Read moreNew Delhi: Apple spent close to $100 billion on research and development over the last five years to stay on ...
Read moreBangalore: Infosys founder NR Narayana Murthy said Tuesday the country faces huge challenges in the field of research in sciences ...
Read more